ID: ALA4104626

Max Phase: Preclinical

Molecular Formula: C11H8F3N3O

Molecular Weight: 255.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ncc[nH]1)c1cccc(C(F)(F)F)c1

Standard InChI:  InChI=1S/C11H8F3N3O/c12-11(13,14)8-3-1-2-7(6-8)9(18)17-10-15-4-5-16-10/h1-6H,(H2,15,16,17,18)

Standard InChI Key:  KYHNZOYETGRSSN-UHFFFAOYSA-N

Associated Targets(non-human)

MDCK-II 565 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 255.20Molecular Weight (Monoisotopic): 255.0619AlogP: 2.68#Rotatable Bonds: 2
Polar Surface Area: 57.78Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.17CX Basic pKa: 3.67CX LogP: 2.51CX LogD: 2.51
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.87Np Likeness Score: -1.70

References

1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH..  (2017)  Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms.,  27  (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063]

Source